Accelerate your R&D program with integrated Drug Discovery Services
Oncodesign Services is a contract research organization (CRO) with over 25 years of experience in early drug discovery and preclinical services, to contribute to the development of innovative therapies against diseases with high medical needs.
We bring the right skills, expertise and discovery platforms to design and deliver new chemical entities in key therapeutic areas: oncology, immuno-oncology, immuno-inflammation and infectious diseases.
Progress your molecule to IND
We have built a team of drug discovery experts to provide innovative solutions through the entire drug discovery journey from hit-finding to IND-filing.
The key objective of Lead Optimization (LO) is to improve the pharmacological profile and DMPK properties of the Lead compound, such as efficacy, safety, pharmacokinetics and pharmacodynamics, to make it suitable for development into a drug candidate.
“YOUR PARTNER TO DELIVER HIGH QUALITY PRECLINICAL CANDIDATES WITH FAST DEVELOPMENT CYCLES AND CUSTOMIZED CHEMICAL STRATEGIES”
Our CRO drug discovery services
for small molecule, biologics and molecular radiotherapy
Oncodesign Services encompasses all drug discovery services to deliver drug candidates including:
1
Medicinal Chemistry
2
Bioanalysis
Bioanalysis
Oncodesign Services offers formulation, immunogenicity and bioanalytical sample analysis services including platforms for small molecules (NCEs), peptides, large molecules (NBEs), monoclonal antibodies (mAb), Antibody-Drug Conjugates (ADC), Anti-Drug Antibodies (ADA), Neutralizing Antibodies (Nab), oligonucleotides (OGN) and biomarkers (simplex/multiplex).
3
In vitro biology
In vitro biology
Oncodesign Services offers both off-the-shell assays using commercial kits and in-house developed assays with customized reagent panels.
4
Pharmaco-Imaging
5
DMPK
DMPK
Oncodesign Services studies the pharmacokinetics and metabolism of your new therapeutic entities.
6
In vivo pharmacology
In vivo pharmacology
From its inception, Oncodesign Services has dedicated efforts to centralize skills, assays and expertise to conduct complete preclinical pharmacological characterization of drugs in the field of oncology, immunology, immune-inflammation or infectious diseases. Our multi-disciplinary team keeps your program moving quickly by providing proof of concept for your lead compounds.
Bioanalysis
Oncodesign Services offers formulation, immunogenicity and bioanalytical sample analysis services including platforms for small molecules (NCEs), peptides, large molecules (NBEs), monoclonal antibodies (mAb), Antibody-Drug Conjugates (ADC), Anti-Drug Antibodies (ADA), Neutralizing Antibodies (Nab), oligonucleotides (OGN) and biomarkers (simplex/multiplex).
In vitro biology
Oncodesign Services offers both off-the-shell assays using commercial kits and in-house developed assays with customized reagent panels.
DMPK
Oncodesign Services studies the pharmacokinetics and metabolism of your new therapeutic entities.
In vivo pharmacology
From its inception, Oncodesign Services has dedicated efforts to centralize skills, assays and expertise to conduct complete preclinical pharmacological characterization of drugs in the field of oncology, immunology, immune-inflammation or infectious diseases. Our multi-disciplinary team keeps your program moving quickly by providing proof of concept for your lead compounds.
Who is Oncodesign Services?
Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. From target identification to IND filing, the company contributes to the development of innovative therapies in oncology, inflammation and infectious diseases, with high medical needs.
Oncodesign Services has 230 employees in France, Canada and the United States.
Contact us for more information!